Clinical Trials in Chicago

Showing 5241-5260 of 20,493 trials

COVID Protection After Transplant - Sanofi GSK (CPAT-SG) Study

NCT05518487

An open label, non-randomized pilot study in kidney transplant recipients who received a completed primary series and bivalent booster of mRNA based COVID-19 vaccine and have ≤2500 U/mL SARS-CoV-2 S antibody concentration using the Roche Elecsys(R) anti-RBD assay. Up to 80 participants will be enrolled in this study. Eligible participants will receive a dose of the Sanofi-GSK monovalent (B.1.351) CoV2 preS dTM-AS03 COVID-19 vaccine candidate.. The primary objective is to determine whether a booster dose of the Sanofi-GSK monovalent (B.1.351) CoV2 preS dTM-AS03 COVID-19 vaccine will elicit an increased SARS-CoV-2 antibody response in participants who have failed to maintain an antibody titer \>2500 U/mL (using the Roche Elecsys(R) anti-RBD assay) to 2 or more doses of mRNA based COVID-19 vaccine

COVID-19Kidney Transplant

National Institute of Allergy and Infectious Diseases (NIAID)15 participantsStarted Feb 2023

San Diego, California, United States • San Francisco, California, United States • Atlanta, Georgia, United States +3 more locations

RECRUITINGPhase 32.2 miles

Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Bowel

NCT05561127

To determine the safety and efficacy of GIE Medical's ProTractX3™ TTS DCB for the treatment of recurrent benign bowel strictures.

Bowel; Stricture

GIE Medical171 participantsStarted Nov 2023

Scottsdale, Arizona, United States • Irvine, California, United States • Lancaster, California, United States +30 more locations

COVID Protection After Transplant - Sanofi GSK (CPAT-SG) Study

Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Bowel

Find Trials by Condition in Chicago

Precision Ventilation vs Standard Care for Acute Respiratory Distress Syndrome

The Ability of Chronic Pain Patients to Self-diagnose Their Chief Source of Low Back Pain

Optimizing the Use of Ketamine to Reduce Chronic Postsurgical Pain

ALT-801 in Overweight and Obese Subjects With Type 2 Diabetes Mellitus (T2DM)

Microcurrent Stimulation Therapy for Nonexudative Age-related Macular Degeneration (i-SIGHT)

Post-Approval Study of the TREO Abdominal Stent-Graft System

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Clinical Activity of GSK5733584 for Injection in Participants With Advanced Solid Tumors

A Study for Participants Previously Treated With Century Therapeutics Cellular Therapy Product

Ixazomib and Dexamethasone Versus Ixazomib, Dexamethasone and Lenalidomide, Randomized With NFKB2 Rearrangement

Efficacy, Safety, and PK of LX9211 in Participants With Diabetic Peripheral Neuropathic Pain

Phase II Study of Short Course FOLFOX Chemotherapy With Either Nivolumab or Nivolumab + Radiation in the First Line Treatment of Metastatic or Unresectable Gastroesophageal Cancers (BMS Protocol CA209-76L)

Clinical Investigation of the Next-Generation Intraocular Lens

Apixaban for the Treatment of Venous Thromboembolism in Patients With Cancer

A Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in Participants With Type 1 Diabetes Treated With Multiple Daily Injection Therapy

International Rare Histiocytic Disorders Registry (IRHDR)

A Phase 1, Open-Label Study of Teprotumumab in Patients With Diabetic Macular Edema (DME)

A First-in-human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of DS-6051b

Implementing Precision Medicine in cOmmunity HospiTALs